Does sustained weight loss reverse the metabolic syndrome?

Current Hypertension Reports

Volumn 13, Issue 6, 2011, Pages 456-464

  Ferland, Annie ^a   Eckel, Robert H ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Abdominal obesity; Anti obesity drugs; Bariatric surgery; Diet; Hyperglycemia; Hypertension; Insulin resistance; Lifestyle intervention; Lipids; Lipoproteins; Metabolic syndrome; Weight loss; Weight maintenance

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; PLACEBO; TETRAHYDROLIPSTATIN; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ARTICLE; BARIATRIC SURGERY; BODY MASS; BORDERLINE HYPERTENSION; CALORIC RESTRICTION; CARBOHYDRATE DIET; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL STUDY; DIABETES MELLITUS; EPIDEMIC; EXERCISE; EXPERIMENTAL DESIGN; GASTROINTESTINAL TOXICITY; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; MEDITERRANEAN DIET; METABOLIC SYNDROME X; PREVALENCE; SODIUM RESTRICTION; WEIGHT REDUCTION;

ANTI-OBESITY AGENTS; BARIATRIC SURGERY; DISEASE PROGRESSION; HUMANS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY, ABDOMINAL; RISK REDUCTION BEHAVIOR; TIME FACTORS; WEIGHT LOSS;

EID: 81255158008     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-011-0221-z     Document Type: Article

References (92)

1. KM Flegal MD Carroll CL Ogden LR Curtin 2010 Prevalence and trends in obesity among US adults, 1999-2008 JAMA 303 3 235 41 20071471 10.1001/jama.2009.2014 1:CAS:528:DC%2BC3cXptVyksA%3D%3D This very important paper reports on the recent increases in obesity prevalence among US adults. The paper also reports that all-cause mortality and mortality from coronary heart disease and stroke have declined over several decades, whereas hypertension appears to be increasing.
2. ES Ford C Li G Zhao 2010 Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US J Diabetes 2 3 180 93 20923483 10.1111/j.1753-0407.2010.00078.x
3. L Perusse C Bouchard 2000 Gene-diet interactions in obesity Am J Clin Nutr 72 5 Suppl 1285S 90 11063470 1:CAS:528:DC%2BD3cXnvF2msLY%3D
4. JP Despres I Lemieux 2006 Abdominal obesity and metabolic syndrome Nature 444 7121 881 7 17167477 10.1038/nature05488 1:CAS:528:DC%2BD28XhtlShtrzF (Pubitemid 46024995)
5. KG Alberti RH Eckel SM Grundy PZ Zimmet JI Cleeman KA Donato, et al. 2009 Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 16 1640 5 19805654 10.1161/CIRCULATIONAHA.109.192644 1:CAS:528:DC%2BD1MXht1OrtrrK This paper attempts to harmonize the criteria for the diagnosis of the MetS. Elevated waist circumference remains one of the criteria, with population-specific and country-specific cutoff standards.
6. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285(19):2486-97.
7. ZT Bloomgarden 2003 American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome: 25-26 August 2002, Washington, DC Diabetes Care 26 4 1297 303 12663612 10.2337/diacare.26.4. 1297 (Pubitemid 36929287)
8. B Balkau MA Charles 1999 Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) Diab Med 16 5 442 3 10.1046/j.1464-5491.1999.00059.x 1:STN:280:DyaK1M3ntFOktg%3D%3D
9. SM Grundy JI Cleeman SR Daniels KA Donato RH Eckel BA Franklin, et al. 2005 Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 17 2735 52 16157765 10.1161/CIRCULATIONAHA.105.169404 (Pubitemid 41532612)
10. SM Grundy B Hansen SC Smith Jr JI Cleeman RA Kahn 2004 Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management Circulation 109 4 551 6 14757684 10.1161/01.CIR.0000112379.88385.67 (Pubitemid 38168522)
11. B Isomaa P Almgren T Tuomi B Forsen K Lahti M Nissen, et al. 2001 Cardiovascular morbidity and mortality associated with the metabolic syndrome Diabetes Care 24 4 683 9 11315831 10.2337/diacare.24.4.683 1:STN:280: DC%2BD3MvjsVOqsw%3D%3D (Pubitemid 32893993)
12. HM Lakka DE Laaksonen TA Lakka LK Niskanen E Kumpusalo J Tuomilehto, et al. 2002 The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men JAMA 288 21 2709 16 12460094 10.1001/jama.288.21.2709 (Pubitemid 35403784)
13. RH Eckel SM Grundy PZ Zimmet 2005 The metabolic syndrome Lancet 365 9468 1415 28 15836891 10.1016/S0140-6736(05)66378-7 1:CAS:528:DC%2BD2MXjsVegtbg%3D (Pubitemid 40523737)
14. P Ilanne-Parikka JG Eriksson J Lindstrom M Peltonen S Aunola H Hamalainen, et al. 2008 Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study Diabetes Care 31 4 805 7 18184907 10.2337/dc07-1117
15. TJ Orchard M Temprosa R Goldberg S Haffner R Ratner S Marcovina, et al. 2005 The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial Ann Intern Med 142 8 611 9 15838067 1:CAS:528:DC%2BD2MXktFahtrY%3D (Pubitemid 40529957)
16. S Yusuf S Hawken S Ounpuu L Bautista MG Franzosi P Commerford, et al. 2005 Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study Lancet 366 9497 1640 9 16271645 10.1016/S0140-6736(05)67663-5 (Pubitemid 41552419)
17. AJ Cameron EJ Boyko RA Sicree PZ Zimmet S Soderberg KG Alberti, et al. 2008 Central obesity as a precursor to the metabolic syndrome in the AusDiab study and Mauritius Obesity 16 12 2707 16 18820650 10.1038/oby.2008.412 1:CAS:528:DC%2BD1MXjvV2itw%3D%3D
18. MC Pouliot JP Despres A Nadeau S Moorjani D Prud'Homme PJ Lupien, et al. 1992 Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels Diabetes 41 7 826 34 1612197 10.2337/diabetes.41.7.826 1:STN:280:DyaK38zgslWnsw%3D%3D
19. JP Despres S Moorjani PJ Lupien A Tremblay A Nadeau C Bouchard 1990 Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease Arteriosclerosis 10 4 497 511 2196040 10.1161/01.ATV.10.4.497 1:CAS:528:DyaK3MXitFKiuw%3D%3D (Pubitemid 20220572)
20. P Poirier JP Despres 2003 Waist circumference, visceral obesity, and cardiovascular risk J Cardiopulm Rehabil 23 3 161 9 12782898 10.1097/00008483-200305000-00001 (Pubitemid 36666838)
21. F Abbasi BW Brown Jr C Lamendola T McLaughlin GM Reaven 2002 Relationship between obesity, insulin resistance, and coronary heart disease risk J Am Coll Cardiol 40 5 937 43 12225719 10.1016/S0735-1097(02)02051-X 1:CAS:528: DC%2BD38Xns1OmsLg%3D (Pubitemid 34994988)
22. GR Dagenais Q Yi JF Mann J Bosch J Pogue S Yusuf 2005 Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease Am Heart J 149 1 54 60 15660034 10.1016/j.ahj.2004.07.009 (Pubitemid 40126490)
23. A Romero-Corral VK Somers J Sierra-Johnson MD Jensen RJ Thomas RW Squires, et al. 2007 Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease Eur Heart J 28 17 2087 93 17626030 10.1093/eurheartj/ehm243 (Pubitemid 47517439)
24. NHLBI Obesity Education Initiative. The practical guide to the identification, evaluation, and treatment of overweight and obesity in adults. 2000:10. Available at http://www.nhlbi.nih.gov/guidelines/obesity/prctgd-c.pdf.
25. JP Despres I Lemieux J Bergeron P Pibarot P Mathieu E Larose, et al. 2008 Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk Arterioscler Thromb Vasc Biol 28 6 1039 49 18356555 10.1161/ATVBAHA.107.159228 1:CAS:528:DC%2BD1cXlsFOjur8%3D
26. MJ Franz JJ VanWormer AL Crain JL Boucher T Histon W Caplan, et al. 2007 Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up J Am Diet Assoc 107 10 1755 67 17904936 10.1016/j.jada.2007.07.017 (Pubitemid 47464109)
27. TA Wadden ML Butryn KJ Byrne 2004 Efficacy of lifestyle modification for long-term weight control Obes Res 12 Suppl 151S 62 15687411 10.1038/oby.2004.282
28. S Toubro A Astrup 1997 Randomised comparison of diets for maintaining obese subjects' weight after major weight loss: ad lib, low fat, high carbohydrate diet v fixed energy intake BMJ 314 7073 29 34 9001476 10.1136/bmj.314.7073.29 1:CAS:528:DyaK2sXhsVOgsrk%3D (Pubitemid 27023233)
29. FM Sacks GA Bray VJ Carey SR Smith DH Ryan SD Anton, et al. 2009 Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates N Engl J Med 360 9 859 73 19246357 10.1056/NEJMoa0804748 1:CAS:528:DC%2BD1MXis1Cnsbs%3D The authors provide evidence that calorie reduction, rather the macronutrient composition of the diet, is most important in inducing clinically meaningful weight loss and improving plasma lipids and lipoproteins and fasting insulin levels.
30. RR Wing JO Hill 2001 Successful weight loss maintenance Annu Rev Nutr 21 323 41 11375440 10.1146/annurev.nutr.21.1.323 1:CAS:528:DC%2BD3MXlvFyku7g%3D (Pubitemid 32695275)
31. ML Klem RR Wing MT McGuire HM Seagle JO Hill 1997 A descriptive study of individuals successful at long-term maintenance of substantial weight loss Am J Clin Nutr 66 2 239 46 9250100 1:CAS:528:DyaK2sXltVagu78%3D (Pubitemid 27360320)
32. HA Raynor RW Jeffery S Phelan JO Hill RR Wing 2005 Amount of food group variety consumed in the diet and long-term weight loss maintenance Obes Res 13 5 883 90 15919842 10.1038/oby.2005.102
33. AA Gorin S Phelan RR Wing JO Hill 2004 Promoting long-term weight control: does dieting consistency matter? Int J Obes Relat Metab Disord 28 2 278 81 14647183 1:STN:280:DC%2BD2c%2FotVyhug%3D%3D (Pubitemid 38223510)
34. BJ Brehm RJ Seeley SR Daniels DA D'Alessio 2003 A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women J Clin Endocrinol Metab 88 4 1617 23 12679447 10.1210/jc.2002-021480 1:CAS:528: DC%2BD3sXjtFClsLg%3D (Pubitemid 36623378)
35. WS Yancy Jr MK Olsen JR Guyton RP Bakst EC Westman 2004 A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial Ann Intern Med 140 10 769 77 15148063
36. AJ Nordmann A Nordmann M Briel U Keller WS Yancy Jr BJ Brehm, et al. 2006 Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials Arch Intern Med 166 3 285 93 16476868 10.1001/archinte.166.3.285 1:CAS:528:DC%2BD28XhvFOnsbc%3D (Pubitemid 43244316)
37. ML Dansinger A Tatsioni JB Wong M Chung EM Balk 2007 Meta-analysis: the effect of dietary counseling for weight loss Ann Intern Med 147 1 41 50 17606960 (Pubitemid 351664633)
38. VS Malik FB Hu 2007 Popular weight-loss diets: from evidence to practice Nat Clin Pract Cardiovasc Med 4 1 34 41 17180148 10.1038/ncpcardio0726 1:CAS:528:DC%2BD2sXhtVClsLk%3D (Pubitemid 44971070)
39. I Shai D Schwarzfuchs Y Henkin DR Shahar S Witkow I Greenberg, et al. 2008 Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet N Engl J Med 359 3 229 41 18635428 10.1056/NEJMoa0708681 1:CAS:528:DC%2BD1cXoslCqu7k%3D (Pubitemid 352008438)
40. GM Turner-McGrievy ND Barnard AR Scialli 2007 A two-year randomized weight loss trial comparing a vegan diet to a more moderate low-fat diet Obesity 15 9 2276 81 17890496 10.1038/oby.2007.270 (Pubitemid 350004095)
41. K McManus L Antinoro F Sacks 2001 A randomized controlled trial of a moderate-fat, low-energy diet compared with a low fat, low-energy diet for weight loss in overweight adults Int J Obes Relat Metab Disord 25 10 1503 11 11673773 10.1038/sj.ijo.0801796 1:STN:280:DC%2BD3Mrms1Ghsw%3D%3D (Pubitemid 32977869)
42. H Lantz M Peltonen L Agren JS Torgerson 2003 A dietary and behavioural programme for the treatment of obesity. A 4-year clinical trial and a long-term posttreatment follow-up J Intern Med 254 3 272 9 12930237 10.1046/j.1365-2796. 2003.01187.x (Pubitemid 37070229)
43. RR Wing S Phelan 2005 Long-term weight loss maintenance Am J Clin Nutr 82 1 Suppl 222S 5 16002825 1:CAS:528:DC%2BD2MXmsVSgsbk%3D
44. KF Eriksson F Lindgarde 1991 Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study Diabetologia 34 12 891 8 1778354 10.1007/BF00400196 1:STN:280: DyaK387jslGnuw%3D%3D
45. J Tuomilehto J Lindstrom JG Eriksson TT Valle H Hamalainen P Ilanne-Parikka, et al. 2001 Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N Engl J Med 344 18 1343 50 11333990 10.1056/NEJM200105033441801 1:STN:280:DC%2BD3M3kvFejsA%3D%3D (Pubitemid 32378388)
46. XR Pan GW Li YH Hu JX Wang WY Yang ZX An, et al. 1997 Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance The Da Qing IGT and Diabetes Study. Diabetes Care 20 4 537 44 1:STN:280: DyaK2s3ltFaqtw%3D%3D
47. WC Knowler E Barrett-Connor SE Fowler RF Hamman JM Lachin EA Walker, et al. 2002 Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 6 393 403 11832527 10.1056/NEJMoa012512 1:CAS:528:DC%2BD38XhtVWqurc%3D (Pubitemid 34437694)
48. CM Alexander PB Landsman SM Teutsch SM Haffner 2003 NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older Diabetes 52 5 1210 4 12716754 10.2337/diabetes.52.5.1210 1:CAS:528:DC%2BD3sXjsFGhur0%3D (Pubitemid 36523358)
49. 1c, systolic blood pressure, and cardiovascular disease risk factors over 4 years of study follow-up
50. LF Van Gaal MA Wauters IH De Leeuw 1997 The beneficial effects of modest weight loss on cardiovascular risk factors Int J Obes Relat Metab Disord 21 Suppl 1 S5 9 9130034
51. LJ Appel MW Brands SR Daniels N Karanja PJ Elmer FM Sacks 2006 Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association Hypertension 47 2 296 308 16434724 10.1161/01.HYP.0000202568.01167.B6 1:CAS:528:DC%2BD28XksFOruw%3D%3D (Pubitemid 43189776)
52. JP Bantle J Wylie-Rosett AL Albright CM Apovian NG Clark MJ Franz, et al. 2008 Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association Diabetes Care 31 Suppl 1 S61 78 18165339 1:CAS:528:DC%2BD1cXhs1ejtLo%3D
53. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106(25):3143-421.
54. AH Lichtenstein LJ Appel M Brands M Carnethon S Daniels HA Franch, et al. 2006 Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee Circulation 114 1 82 96 16785338 10.1161/CIRCULATIONAHA.106.176158 (Pubitemid 44305278)
55. M de Lorgeril P Salen JL Martin I Monjaud J Delaye N Mamelle 1999 Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study Circulation 99 6 779 85 9989963 (Pubitemid 29083018)
56. L Aucott D Gray H Rothnie M Thapa C Waweru 2011 Effects of lifestyle interventions and long-term weight loss on lipid outcomes - A systematic review Obes Rev 12 501 e412 25 21371252 10.1111/j.1467-789X.2010.00819.x 1:STN:280:DC%2BC3MvksVKjtw%3D%3D
57. PH Barrett GF Watts 2003 Kinetic studies of lipoprotein metabolism in the metabolic syndrome including effects of nutritional interventions Curr Opin Lipidology 14 1 61 8 10.1097/00041433-200302000-00011 1:CAS:528: DC%2BD3sXlsV2mtw%3D%3D (Pubitemid 36183103)
58. SJ Ley PA Metcalf RK Scragg BA Swinburn 2004 Long-term effects of a reduced fat diet intervention on cardiovascular disease risk factors in individuals with glucose intolerance Diabetes Res Clin Pract 63 2 103 12 14739050 10.1016/j.diabres.2003.09.001 1:CAS:528:DC%2BD2cXkvF2jtQ%3D%3D (Pubitemid 38096355)
59. BM Egan Y Zhao RN Axon 2010 US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008 JAMA 303 20 2043 50 20501926 10.1001/jama.2010.650 1:CAS:528:DC%2BC3cXntVWrtLg%3D
60. R Stamler J Stamler R Grimm FC Gosch P Elmer A Dyer, et al. 1987 Nutritional therapy for high blood pressure. Final report of a four-year randomized controlled trial-the Hypertension Control Program JAMA 257 11 1484 91 3546747 10.1001/jama.257.11.1484 1:STN:280:DyaL2s7ktFGiug%3D%3D (Pubitemid 17070866)
61. LJ Appel TJ Moore E Obarzanek WM Vollmer LP Svetkey FM Sacks, et al. 1997 A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group N Engl J Med 336 16 1117 24 9099655 10.1056/NEJM199704173361601 1:STN:280:DyaK2s3jvVOmsA%3D%3D (Pubitemid 27374693)
62. WM Vollmer FM Sacks J Ard LJ Appel GA Bray DG Simons-Morton, et al. 2001 Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial Ann Intern Med 135 12 1019 28 11747380 1:CAS:528: DC%2BD38XlvFKltQ%3D%3D (Pubitemid 33151023)
63. FM Sacks LP Svetkey WM Vollmer LJ Appel GA Bray D Harsha, et al. 2001 Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group N Engl J Med 344 1 3 10 11136953 10.1056/NEJM200101043440101 1:STN:280: DC%2BD3M7ksVSqsQ%3D%3D (Pubitemid 32064838)
64. S Anderssen I Holme P Urdal I Hjermann 1995 Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: the Oslo Diet and Exercise Study (ODES) Blood Press 4 6 343 9 8746601 10.3109/08037059509077619 1:STN:280:DyaK28zls1artA%3D%3D (Pubitemid 26019454)
65. PK Whelton LJ Appel MA Espeland WB Applegate WH Ettinger Jr JB Kostis, et al. 1998 Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group JAMA 279 11 839 46 9515998 10.1001/jama.279.11.839 1:STN:280:DyaK1c7nsFOmsQ%3D%3D (Pubitemid 28185548)
66. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group. Arch Intern Med. 1997;157(6):657-67.
67. BR Davis MD Blaufox A Oberman S Wassertheil-Smoller N Zimbaldi JA Cutler, et al. 1993 Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension Arch Intern Med 153 15 1773 82 8333814 10.1001/archinte.153. 15.1773 1:STN:280:DyaK3szis1SktQ%3D%3D (Pubitemid 23221495)
68. J Hauptman 2000 Orlistat: selective inhibition of caloric absorption can affect long-term body weight Endocrine 13 2 201 6 11186221 10.1385/ENDO:13:2:201 1:CAS:528:DC%2BD3cXotFajsLg%3D
69. S Rossner L Sjostrom R Noack AE Meinders G Noseda 2000 Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group Obes Res 8 1 49 61 10678259 10.1038/oby.2000.8 1:CAS:528:DC%2BD3cXpvF2msQ%3D%3D
70. J Hauptman C Lucas MN Boldrin H Collins KR Segal 2000 Orlistat in the long-term treatment of obesity in primary care settings Arch Fam Med 9 2 160 7 10693734 10.1001/archfami.9.2.160 1:STN:280:DC%2BD3c7lsFCjsw%3D%3D
71. SB Heymsfield KR Segal J Hauptman CP Lucas MN Boldrin A Rissanen, et al. 2000 Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults Arch Intern Med 160 9 1321 6 10809036 10.1001/archinte.160.9.1321 1:CAS:528:DC%2BD3cXjslKnsLc%3D (Pubitemid 30252779)
72. L Sjostrom A Rissanen T Andersen M Boldrin A Golay HP Koppeschaar, et al. 1998 Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group Lancet 352 9123 167 72 9683204 10.1016/S0140-6736(97)11509-4 1:CAS:528:DyaK1cXlt1altbo%3D (Pubitemid 28327800)
73. MH Davidson J Hauptman M DiGirolamo JP Foreyt CH Halsted D Heber, et al. 1999 Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial JAMA 281 3 235 42 9918478 10.1001/jama.281.3.235 1:CAS:528:DyaK1MXhtFSqtr8%3D (Pubitemid 29058112)
74. JS Torgerson J Hauptman MN Boldrin L Sjostrom 2004 XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients Diabetes Care 27 1 155 61 14693982 10.2337/diacare.27.1.155 1:CAS:528:DC%2BD2cXmvV2jug%3D%3D (Pubitemid 38196725)
75. B Richelsen S Tonstad S Rossner S Toubro L Niskanen S Madsbad, et al. 2007 Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study Diabetes Care 30 1 27 32 17192328 10.2337/dc06-0210 1:CAS:528:DC%2BD2sXhsFWqtLs%3D (Pubitemid 46052496)
76. M Svedsen M Helgeland S Tonstad 2009 The long-term influence of orlistat on dietary intake in obese subjects with component of metabolic syndrome J Hum Nutr Diet 22 1 55 63 10.1111/j.1365-277X.2008.00920.x
77. PA Hollander SC Elbein IB Hirsch D Kelley J McGill T Taylor, et al. 1998 Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study Diabetes Care 21 8 1288 94 9702435 10.2337/diacare.21.8.1288 1:STN:280:DyaK1czmslyisA%3D%3D (Pubitemid 28365685)
78. Czernichow S, Knol MJ, Fezeu L, Grobbee DE. Impact of orlistat initiation on cardiovascular treatment use: a 6-year population-based cohort study. Eur J Cardiovasc Prev Rehabil. 2011 Apr 4 (Epub ahead of print).
79. Athyros VG, Ganotakis E, Kolovou GD, Nicolaou V, Achimastos A, Bilianou E, Alexandrides T, Karagiannis A, Paletas K, Liberopoulos EN, et al. Assessing The Treatment Effect in Metabolic Syndrome without Perceptible Diabetes (ATTEMPT): a prospective-randomized study in middle aged men and women. Curr Vasc Pharmacol. 2011 Apr 11 (Epub ahead of print).
80. P Poirier MA Cornier T Mazzone S Stiles S Cummings S Klein, et al. 2011 Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association Circulation 123 15 1683 701 21403092 10.1161/CIR.0b013e3182149099
81. H Buchwald Y Avidor E Braunwald MD Jensen W Pories K Fahrbach, et al. 2004 Bariatric surgery: a systematic review and meta-analysis JAMA 292 14 1724 37 15479938 10.1001/jama.292.14.1724 1:CAS:528:DC%2BD2cXos1OjtLg%3D (Pubitemid 39346675)
82. MA Maggard LR Shugarman M Suttorp M Maglione HJ Sugerman EH Livingston, et al. 2005 Meta-analysis: surgical treatment of obesity Ann Intern Med 142 7 547 59 15809466
83. WJ Pories 2008 Bariatric surgery: risks and rewards J Clin Endocrinol Metab 93 11 Suppl 1 S89 96 18987275 10.1210/jc.2008-1641 1:CAS:528: DC%2BD1cXhtlOqurvN
84. TK Alexandrides G Skroubis F Kalfarentzos 2007 Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity Obes Surg 17 2 176 84 17476868 10.1007/s11695-007-9044-z (Pubitemid 47091578)
85. WJ Pories MS Swanson KG MacDonald SB Long PG Morris BM Brown, et al. 1995 Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus Ann Surg 222 3 339 50 7677463 10.1097/00000658-199509000-00011 1:STN:280:DyaK2Mvgsl2ltA%3D%3D discussion 350-332
86. L Sjostrom AK Lindroos M Peltonen J Torgerson C Bouchard B Carlsson, et al. 2004 Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery N Engl J Med 351 26 2683 93 15616203 10.1056/NEJMoa035622 (Pubitemid 39665322)
87. KG MacDonald Jr SD Long MS Swanson BM Brown P Morris GL Dohm, et al. 1997 The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus J Gastrointest Surg 1 3 213 20 9834350 10.1016/S1091-255X(97)80112-6 discussion 220 (Pubitemid 127432762)
88. JL Azevedo Jr JO Carey WJ Pories PG Morris GL Dohm 1995 Hypoxia stimulates glucose transport in insulin-resistant human skeletal muscle Diabetes 44 6 695 8 7789635 10.2337/diabetes.44.6.695 1:CAS:528:DyaK2MXmt1antbk%3D
89. C Gasteyger M Suter JM Calmes RC Gaillard V Giusti 2006 Changes in body composition, metabolic profile and nutritional status 24 months after gastric banding Obes Surg 16 3 243 50 16545153 10.1381/096089206776116381 1:STN:280:DC%2BD287lvVSjsw%3D%3D
90. AK Madan W Orth CA Ternovits DS Tichansky 2006 Metabolic syndrome: yet another co-morbidity gastric bypass helps cure Surg Obes Relat Dis 2 1 48 51 16925317 10.1016/j.soard.2005.09.014 discussion 51
91. F Folli AE Pontiroli WH Schwesinger 2007 Metabolic aspects of bariatric surgery The Medical Clinics of North America 91 3 393 414 17509385 10.1016/j.mcna.2007.01.005 1:CAS:528:DC%2BD2sXntFOmtbo%3D x (Pubitemid 46726487)
92. AM Wolf U Beisiegel B Kortner HW Kuhlmann 1998 Does gastric restriction surgery reduce the risks of metabolic diseases? Obes Surg 8 1 9 13 9562480 10.1381/096089298765554980 1:STN:280:DyaK1c3itV2ksA%3D%3D (Pubitemid 28143539)